Role of tetrahydrobiopterin (BH4) in hyperhomocysteinemia-induced endothelial dysfuction: new indication for this orphan-drug?
1Maastricht University Medical Centre.
Journal Article: AJP Endocrinology and Metabolism (impact factor: 4.4). 03/2011; 300(6):E1176; author reply E1177-8. DOI: 10.1152/ajpendo.00084.2011
Abstract
n/a.
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Science & Research Jobs
**Experienced Contract CRA's required to join a Leading Global Healthcare Company**
Position: Clinician
Employer: Max Resourcing
